High Net Worth Advisory Group LLC lowered its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 14.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,925 shares of the company’s stock after selling 1,552 shares during the period. High Net Worth Advisory Group LLC’s holdings in Kenvue were worth $206,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also modified their holdings of the company. Massmutual Trust Co. FSB ADV grew its stake in Kenvue by 6.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 8,400 shares of the company’s stock worth $194,000 after acquiring an additional 492 shares in the last quarter. Marathon Capital Management increased its holdings in Kenvue by 0.3% during the second quarter. Marathon Capital Management now owns 149,699 shares of the company’s stock valued at $2,722,000 after buying an additional 514 shares during the period. Manchester Capital Management LLC raised its stake in Kenvue by 80.8% in the first quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock worth $25,000 after buying an additional 530 shares in the last quarter. Poehling Capital Management INC. lifted its holdings in Kenvue by 0.5% during the second quarter. Poehling Capital Management INC. now owns 104,934 shares of the company’s stock worth $1,908,000 after buying an additional 547 shares during the period. Finally, Pathway Financial Advisers LLC boosted its position in Kenvue by 12.0% during the 2nd quarter. Pathway Financial Advisers LLC now owns 5,131 shares of the company’s stock valued at $93,000 after acquiring an additional 549 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Wall Street Analyst Weigh In
KVUE has been the subject of several recent research reports. UBS Group boosted their price target on Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Piper Sandler boosted their price objective on shares of Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, September 23rd. JPMorgan Chase & Co. raised their target price on Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a research note on Friday. Citigroup lowered their price target on Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a research report on Wednesday, July 10th. Finally, Royal Bank of Canada lowered Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective on the stock. in a report on Tuesday, September 24th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Kenvue currently has an average rating of “Hold” and a consensus price target of $22.20.
Kenvue Stock Up 0.7 %
Shares of KVUE opened at $21.46 on Monday. The stock’s 50-day moving average price is $22.13 and its 200-day moving average price is $20.18. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $41.09 billion, a price-to-earnings ratio of 27.51, a PEG ratio of 2.76 and a beta of 1.40. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $23.55.
Kenvue (NYSE:KVUE – Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The business had revenue of $4 billion for the quarter, compared to analysts’ expectations of $3.93 billion. During the same quarter last year, the company earned $0.32 EPS. The business’s revenue was down .3% on a year-over-year basis. On average, sell-side analysts predict that Kenvue Inc. will post 1.08 EPS for the current year.
Kenvue Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 28th. Stockholders of record on Wednesday, August 14th were given a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, August 14th. This is a boost from Kenvue’s previous quarterly dividend of $0.20. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.82%. Kenvue’s dividend payout ratio (DPR) is 105.13%.
Kenvue Company Profile
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Featured Articles
- Five stocks we like better than Kenvue
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Stocks Under $20 for Buy-and-Hold Investors Seeking Growth
- Industrial Products Stocks Investing
- BlackRock’s Earnings Reveal Market Shift: Why Bonds Are in Favor
- What is the Nikkei 225 index?
- JPMorgan Can Hit New Highs This Year: Here’s Why
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.